Clinical trial

Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)

NCT06610734

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-12-23

PhasePHASE2

Study timeline

Study start (actual)2024-12-23Date precision: day

Registry last updated2026-02-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Small Cell Lung Cancer Extensive Stageunresolved

Interventions

AdebrelimabDRUG

ChemotherapyDRUG

low dose radiotherapyRADIATION

Sponsors & collaborators

Sichuan Universitylead sponsor

Shanghai Shengdi Pharmaceutical Co., Ltdcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06610734 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.